AMICUS THERAPEUTICS INCAMICUS THERAPEUTICS INCAMICUS THERAPEUTICS INC

AMICUS THERAPEUTICS INC

No trades
See on Supercharts

Price target

308.790.00 0.00%
The 9 analysts offering 1 year price forecasts for FOLD have a max estimate of — and a min estimate of —.

Analyst rating

Based on 11 analysts giving stock ratings to FOLD in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

FOLD EPS for the last quarter is −1.87 MXN despite the estimation of −0.98 MXN. In the next quarter EPS is expected to reach −1.07 MXN. Track more of AMICUS THERAPEUTICS INC financials and stay on top of what is up with the company.
In the next quarter AMICUS THERAPEUTICS INC revenue is expected to reach ‪1.84 B‬ MXN. Check out AMICUS THERAPEUTICS INC revenue and earnings and make informed decisions.
According to analysts, FOLD price target is 308.79 MXN with a max estimate of 361.78 MXN and a min estimate of 230.23 MXN. Check if this forecast comes true in a year, meanwhile watch AMICUS THERAPEUTICS INC stock price chart and keep track of the current situation with FOLD news and stock market news.
We've gathered opinions of 11 analysts rating FOLD stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.